Our study demonstrates that Aβ pathology drives the upregulation of microglial GPC4 in Alzheimer’s disease which, in conjunction with APOE, amplifies tau pathology. This evidence concerns the gene GPC4 and early-onset autosomal dominant Alzheimer disease.